Literature DB >> 29900575

Group regularization for zero-inflated negative binomial regression models with an application to health care demand in Germany.

Saptarshi Chatterjee1, Shrabanti Chowdhury2, Himel Mallick3,4, Prithish Banerjee5, Broti Garai6.   

Abstract

In many biomedical applications, covariates are naturally grouped, with variables in the same group being systematically related or statistically correlated. Under such settings, variable selection must be conducted at both group and individual variable levels. Motivated by the widespread availability of zero-inflated count outcomes and grouped covariates in many practical applications, we consider group regularization for zero-inflated negative binomial regression models. Using a least squares approximation of the mixture likelihood and a variety of group-wise penalties on the coefficients, we propose a unified algorithm (Gooogle: Group Regularization for Zero-inflated Count Regression Models) to efficiently compute the entire regularization path of the estimators. We investigate the finite sample performance of these methods through extensive simulation experiments and the analysis of a German health care demand dataset. Finally, we derive theoretical properties of these methods under reasonable assumptions, which further provides deeper insight into the asymptotic behavior of these approaches. The open source software implementation of this method is publicly available at: https://github.com/himelmallick/Gooogle.
Copyright © 2018 John Wiley & Sons, Ltd.

Keywords:  bi-level variable selection; group LASSO; group bridge; group regularization; health care demand; zero-inflated negative binomial

Mesh:

Year:  2018        PMID: 29900575     DOI: 10.1002/sim.7804

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  1 in total

1.  On the rank-deficient canonical correlation technique solved by analytic spectral decomposition.

Authors:  Lukáš Malec
Journal:  J Appl Stat       Date:  2020-11-11       Impact factor: 1.416

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.